Breaking News
Sort by:
Top Post
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
ProBioGen, a Berlin-based specialist for developing and manufacturing biopharmaceutical active ingredients, viral vectors and vaccines, and […]
Vertex and CRISPR Therapeutics Complete Submission of Rolling Biologics License Applications (BLAs) to the FDA
Vertex Pharmaceuticals and CRISPR Therapeutics today announced the completion of the rolling Biologics License Applications […]
Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases
Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors (GPCRs), today […]
MIMETAS and Astellas Enter into Strategic Partnership
MIMETAS, a global leader in human disease modeling, announces that it has entered into a […]
Ratio Therapeutics Announces Licensing Agreement for Investigational PET Imaging Agent with Merck
Ratio Therapeutics, a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class […]
Sonoma Biotherapeutics and Regeneron Announce Collaboration to Discover, Develop and Commercialize T Cell Therapies
Sonoma Biotherapeutics and Regeneron Pharmaceuticals today announced a collaboration to apply their scientific and clinical expertise […]
NeuroSense Therapeutics & Massachusetts General Hospital's NeuroEpigenetics Lab to Collaborate on Elucidating Neurotherapeutic Effects of PrimeC in ALS
NeuroSense Therapeutics, a company developing treatments for severe neurodegenerative diseases, today announced it has signed […]
Vertex and CRISPR Therapeutics Announce Licensing Agreement
Vertex Pharmaceuticals and CRISPR Therapeutics today announced that they have entered into a new non-exclusive […]
EVERSANA® Announces Partnership with ChemoMouthpiece, LLC to Support U.S. Launch & Commercialization of Medical Device to Help Cancer Patients Manage and Treat Oral Mucositis
EVERSANA, a leading provider of commercialization services to the life science industry, today announced a […]
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
Massive Bio, a private AI-enabled oncology startup that provides virtual and in-person concierge services for […]
TaiGen Enters Exclusive License Agreement with Joincare for TG-1000 in China
TaiGen Biotechnology Company announces that they have signed an exclusive licensing agreement with Joincare Pharmaceutical […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more